Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy

Cell Calcium

Volumn 58, Issue 2, 2015, Pages 186-195

  Kyrychenko, Victoria ^a,b   Poláková, Eva ^a,c   Janíček, Radoslav ^a   Shirokova, Natalia ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dystrophic cardiomyopathy; Metabolism; Mitochondria; Oxidative stress; Sodium overload

Indexed keywords

CALCIUM ION; CYCLOSPORIN A; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; SODIUM; CALCIUM; CARRIER PROTEIN; CYCLOSPORIN; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CARDIOMYOPATHY; CELL LEVEL; CELL STRUCTURE; CONTROLLED STUDY; CYTOSOL; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIC CARDIOMYOPATHY; HEART MUSCLE CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; HEART MITOCHONDRION; METABOLISM; PATHOLOGY; ULTRASTRUCTURE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CALCIUM; CELLS, CULTURED; CYCLOSPORINE; CYTOSOL; DISEASE MODELS, ANIMAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MUSCULAR DYSTROPHY, DUCHENNE; MYOCYTES, CARDIAC; NAD; OXIDATIVE STRESS; SODIUM;

EID: 84952716743     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2015.04.006     Document Type: Article

References (34)

1. 2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ. Res. 2006, 99:172-182.
2. Williams G.S.B., Boyman L., Lederer W.J. Mitochondrial calcium and the regulation of metabolism in the heart. J. Mol. Cell. Cardiol. 2014, 78:35-45.
3. + increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 2010, 121:1606-1613.
4. + and cardiac metabolism. J. Mol. Cell. Cardiol. 2013, 61:20-27.
5. Dedkova E.N., Blatter L.A. Calcium signaling in cardiac mitochondria. J. Mol. Cell. Cardiol. 2013, 58:125-133.
6. 2+ and reactive oxygen species signaling. J. Cell Sci. 2013, 126:2965-2978.
7. 2+ signals in stressed mdx dystrophic skeletal muscle fibers. Pflugers Arch. 2009, 458:915-928.
8. Finsterer J., Stöllberger C. The heart in human dystrophinopathies. Cardiology 2003, 99:1-19.
9. 2+ channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H767-H775.
10. 2+ signalling and reactive oxygen species-generating pathways. Cardiovasc. Res. 2007, 77:766-773.
11. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 1993, 122:809-823.
12. 2+ signaling and EC-coupling. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2012, 1833:866-875.
13. Shirokova N., Niggli E. Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies. J. Mol. Cell. Cardiol. 2013, 58:217-224.
14. Kyrychenko S., Polakova E., Kang C., Pocsai K., Ullrich N.D., Niggli E., et al. Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy. Cardiovasc. Res. 2013, 97:666-675.
15. Lisa F.D., Canton M., Menabò R., Kaludercic N., Bernardi P. Mitochondria and cardioprotection. Heart Fail. Rev. 2007, 12:249-260.
16. Williams I.A., Allen D.G. Intracellular calcium handling in ventricular myocytes from mdx mice. Am. J. Physiol. Heart Circ. Physiol. 2006, 292:H846-H855.
17. Williams I.A., Allen D.G. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1969-H1977.
18. Kuznetsov A.V., Winkler K., Wiedemann F.R., von Bossanyi P., Dietzmann K., Kunz W.S. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol. Cell. Biochem. 1998, 183:87-96.
19. Robert V. Alteration in calcium handling at the subcellular level in mdx myotubes. J. Biol. Chem. 2000, 276:4647-4651.
20. Prosser B.L., Ward C.W., Lederer W.J. X-ROS signaling: rapid mechano-chemo transduction in heart. Science 2011, 333:1440-1445.
21. Reutenauer J., Dorchies O.M., Patthey-Vuadens O., Vuagniaux G., Ruegg U.T. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br. J. Pharmacol. 2009, 155:574-584.
22. Ascah A., Khairallah M., Daussin F., Bourcier-Lucas C., Godin R., Allen B.G., et al. Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H144-H153.
23. Percival J.M., Siegel M.P., Knowels G., Marcinek D.J. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. Hum. Mol. Genet. 2012, 22:153-167.
24. Poláková E., Shirokova N. Abnormal sodium handling and mitochondrial metabolism in cardiac dystrophy. Biophys. J. 2011, 100:81a.
25. 2+ influx into dystrophic mdx cardiomyocytes. Cell Calcium 2009, 46:114-121.
26. + exchanger. J. Cell Sci. 1999, 112(Pt 7):1013-1022.
27. Gandhi S., Wood-Kaczmar A., Yao Z., Plun-Favreau H., Deas E., Klupsch K., et al. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell 2009, 33:627-638.
28. 2+-signalling to intracellular pH. J. Mol. Cell. Cardiol. 2013, 61:51-59.
29. Erickson J.R., Joiner M.-L.A., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
30. 2+ release events in mouse cardiomyocytes. Biophys. J. 2014, 107:2815-2827.
31. Weiss J.N. Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 2003, 93:292-301.
32. Ruegg U.T., Nicolas-Métral V., Challet C., Bernard-Hélary K., Dorchies O.M., Wagner S., et al. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle. Neuromuscul. Disord. 2002, 12(Suppl. 1):S155-S161.
33. Burelle Y., Khairallah M., Ascah A., Allen B.G., Deschepper C.F., Petrof B.J., et al. Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart. J. Mol. Cell. Cardiol. 2010, 48:310-321.
34. Millay D.P., Sargent M.A., Osinska H., Baines C.P., Barton E.R., Vuagniaux G., et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med. 2008, 14:442-447.